Author

Ruyue Li

Institutions: Weifang Medical University, Shandong Tumor Hospital, Ningxia Medical University, Ningxia Medical University General Hospital, Shandong First Medical University

Observed institutions: Weifang Medical University, Shandong Tumor Hospital, Ningxia Medical University, Ningxia Medical University General Hospital, Shandong First Medical University

ORCID: 0009-0006-2086-4131

Observed ORCID: 0009-0006-2086-4131

OpenAlex ID: A5113362264

Construction organoid model of ovarian endometriosis and the function of estrogen and progesterone in the model

2025 · Ruiqi Zhang, Yu’e Yang, et al. · Scientific Reports · 24

Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis

2024 · Shaohan Ma, Ruyue Li, et al. · Computers in Biology and Medicine · 13

Efficacy and safety of immunotherapy plus chemotherapy in advanced or metastatic pulmonary large-cell neuroendocrine carcinoma

2025 · Ruyue Li, Huanle Zhang, et al. · Discover Oncology · 12

Adjuvant treatment after neoadjuvant immunotherapy in patients with non-small cell lung cancer

2024 · Junfeng Zhao, Ying Li, et al. · iScience · 7

Treatment options for tumor progression after initial immunotherapy in advanced non-small cell lung cancer: A real-world study

2024 · Ying Li, Junfeng Zhao, et al. · Neoplasia · 6

Deciphering the Molecular Crosstalk of Endoplasmic Reticulum Stress and Immune Infiltration in Endometriosis

2025 · Yuan Ma, Chunfang Ha, et al. · American Journal of Reproductive Immunology · 3

Treatment Options after Progression of First-Line Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review, Meta-Analysis, and Network Meta-Analysis

2025 · Ying Li, Junfeng Zhao, et al. · SSRN Electronic Journal

Works count: 7

Citation count: 65

H-index: 5

I10-index: 3